Corporate Headquarters
1900 Avenue of the Stars
Suite 310
Los Angeles, CA 90067
310.843.9300
Fax: 310.843.9304
Offices located nationwide,
please call for a location nearest you
|
China
Biopharmaceuticals Holdings, Inc. Retains
Investment Bank Wellfleet Partners, Inc.
and its Affiliates to Advise on Financings
and Strategic Initiatives and Procure
Bridge Funding.
January 6, 2005
COMPANY TO
ADVANCE PLANS FOR GROWTH
NEW YORK, NY – China
Biopharmaceuticals Holdings, Inc. (CBH)
announced that it has retained Investment
Bank Wellfleet Partners (WPs or Wellfleet)
to advise the Company on financing opportunities
as well as strategic initiatives, and subsequently
closed a $500,000 Convertible Bridge Loan
the first week in January 2005 through
its broker-dealer relationship with WestPark
Capital (WPC or WestPark).
“Having previously
worked with many companies in the pharmaceutical
services sector, we have developed a great
understanding of the space, and we look
forward to lending our expertise to the
execution of the Company's strategic growth
plans. This is our first foray into China
and we thank our Senior Advisors Stan Wunderlich,
for the introduction, and Dr. Robin Smith,
for her superior efforts,” stated
Mark I. Lev, Chairman and CEO of WPs.
"We have established
a solid track record of performance in
Asia, particularly China, and we look forward
to assisting Wellfleet with its recently
signed client,” stated Richard Rappaport,
Chief Executive Officer at WestPark.
ABOUT CHINA
BIOPHARMACEUTICALS HOLDINGS, INC.
China Biopharmaceuticals
Holdings, Inc (CBH) is focused on developing
and commercializing innovative drugs in
China. The Company operates from a solid
foundation of intergraded resources and
capabilities including:
- Advanced R&D capabilities unmatched
in China ;
- A full product pipeline of new drugs
and proprietary drug discovery platforms;
- Exclusive partnerships with the China
Pharmaceutical University and China
New Drug Development Center, through
a joint venture drug development center
and lab; and
- Experienced management with a history
of success in innovative drug development
and commercialization in China .
CBH's integrated R&D
technology platforms represent the most
advanced drug discovery and development
tools able to analyze the chemical compounds
and natural substances of new drugs and
traditional Chinese medicines. Based on
proprietary gene-level biotechnology made
possible by rapid advances in the post-genomics
era, the platforms have high commercial
value because of their ability to rapidly
identify new chemical compounds and target
them to specific diseases. It is anticipated
that CBH will be a publicly traded company
in January 2005.
ABOUT WELLFLEET
PARTNERS, INC.
Wellfleet Partners,
Inc. ( WPs or Wellfleet )
is a boutique investment and merchant
banking, venture capital and financial
services and consulting firm, which was
founded by Mark I. Lev in early 1998.
The Company's emphasis is to engage in
a wide variety of corporate finance,
venture capital, management consulting,
short-term bridge loans and various fundraising
activities for public and private companies
(through affiliates) and corporate Investment
Banking related activities to a broad
range of emerging small to medium sized
growth companies. In addition, through
subsidiaries and/or affiliates, it offers
financial and brokerage services and
money management as well and has strategic
partnerships in England, Europe and Florida
and now Southern California (Los Angeles & San
Diego) as well as Northern California
(Palo Alto). WPs employees render their
brokerage related activities through
and are registered with WestPark Capital,
Inc. For more information, please got
to www.wellfleetpartners.com
Brochure/newsletter available upon
request.
For further information,
please contact:
Michelle-Lee Cona – Michelle@Wellfleetpartners.com (re
WPs )
Stanley Wunderlich – Swunderlich@Wellfleetpartners.com
(re CBH )
Wellfleet Partners, Inc. (212) 714-0400,
Fax (212) 714-1835
1Penn Plaza , Suite 2032
New York , NY 10119
www.wellfleetpartners.com
ABOUT WESTPARK CAPITAL, INC.
WestPark Capital, Inc. is a full service
investment banking and securities brokerage
firm that serves the needs of both private
and public companies worldwide, as well
as individual and institutional investors. WestPark
is committed to forging lasting partnerships
with emerging growth companies and the
investors who back them. WestPark's
approach is to provide customized financial
solutions for virtually any need. A
complete range of investment banking and
brokerage services is available to corporate
and individual clients. WestPark's corporate
finance professionals have the depth of
experience and resources to create integrated
financing solutions for both private and
public marketplaces. Additionally,
WestPark offers an exceptional array of
private client services through its dedicated
group of financial consultants. WestPark
Capital understands the importance of strong
relationships in today's dynamic business
environment and welcomes the opportunity
to leverage this power into success for
its customers.
For more information visit www.wpcapital.com .
For further information,
please contact:
Richard Rappaport
Anthony Pintsopoulos
WestPark Capital, Inc. (310) 843-9300
1900 Avenue of the Stars, Suite 310
Los Angeles, CA 90067
http://www.wpcapital.com |
International
Locations*
Beijing, China
Shanghai, China
Hong
Kong
Taipei, Taiwan
Canada |